TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS: Review: Depression and Diabetes

Vancampfort, Davy, Mitchell, Alex J., De Hert, Marc, Sienaert, Pascal, Probst, Michel, Buys, Roselien, Stubbs, Brendon·2015·Depression and Anxiety
DOI 10.1002/da.22387

Cited by (171)

Items 101–171 of 171

  1. Effect of Sertraline as an Add-on Therapy in T2DM Patients with Comorbid Depression: An Open Label Randomized Controlled Trial
    Padala R. Kumar, Anindita Chatterjee, Jayanti P. Behera, Sudhiranjan Patnaik · 2019 · Indian Journal of Endocrinology and Metabolism
  2. Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review
    Jan Dahrendorff, Glenn W. Currier, Monica Uddin · 2024 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  3. Noninsulin Diabetes Medications
    Sigi S. Varghese · 2017 · Nursing Clinics of North America
  4. Sex‐specific impact of major depressive disorder on 12‐year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany
    Julia Nübel, Julia Truthmann, Christin Heidemann, Yong Du, Rebecca Paprott, Ulfert Hapke, Johannes Kruse, Christa Scheidt‐Nave, Jens J Baumert · 2021 · Diabetic Medicine
  5. Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications
    Susanne U. Miedlich, J. Steven Lamberti · 2025 · Annals of the New York Academy of Sciences
  6. Physical Activity and Exercise as a Treatment of Depression: Evidence and Neurobiological Mechanism
    Brendon Stubbs, Felipe Barreto Schuch · 2019 · Elsevier eBooks
  7. Sargassum sagamianum Extract Alleviates Postprandial Hyperglycemia in Diabetic Mice
    Ji-Soo Lee, Ji-Sook Han · 2018 · Preventive Nutrition and Food Science
  8. Prevalence of depression and anxiety symptoms by liver disease etiology
    Doyle, Todd, Schmidt, Benjamin, Scaglione, Steve · 2023 · Clinical Liver Disease
  9. A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders
    Yoriyasu Uju, Tetsuto Kanzaki, Yuki Yamasaki, Tadayuki Kondo, Hideki Nanasawa, Yu Takeuchi, Yuta Yanagisawa, Shun Kusanishi, Chieko Nakano, Tetsuro Enomoto et al. · 2020 · Annals of General Psychiatry
  10. Disability and Comorbidity of Mood Disorders and Anxiety Disorders With Diabetes and Hypertension: Evidences From the China Mental Health Survey and Chronic Disease Surveillance in China
    Yuanyuan Hu, Yueqin Huang, Limin Wang, Zhaorui Liu, Linhong Wang, Jie Yan, Mei Zhang, Ping Lv, Yunqi Guan, Chao Ma et al. · 2022 · Frontiers in Psychiatry
  11. Mendelian randomization shows depression increases the risk of type 2 diabetes
    Sungho Won, Sanghun Lee, Jeewon Lee, Sanghun Lee, Sohee Oh · 2023 · Frontiers in Genetics
  12. RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY
    Chun-Yuan Lin, Yu‐Hsin Wu, Hong-Song Wang, Ping-Kun Chen, Yuan-Fu Lin, I‐Chia Chien · 2016 · Depression and Anxiety
  13. The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study
    Elisa Macedo Brietzke, Alisson Paulino Trevizol, Gabriel R. Fries, Mehala Subramaniapillai, Flávio Pereira Kapczinski, Roger S. McIntyre, Rodrigo Barbachan Mansur · 2018 · Journal of Psychiatric Research
  14. Preferences of patients with depression for exercises: a discrete choice experiment
    Huiqin Li, Peng Ping Xie, Yu Hou, Weixin Jiang, Shiwei Gong, Si Jin · 2025 · BMC Public Health
  15. Diagnosing major depressive disorder and substance use disorder using the electronic health record: A preliminary validation study
    Vinod Rao, Sylvia R. Lanni, Amy M. Yule, Maura DiSalvo, Mira Stone, Amy F. Berger, Timothy E. Wilens · 2023 · Journal of Mood and Anxiety Disorders
  16. Exercise for depression treatment. Exercise modalities and types
    V. V. Gultyaeva, Margarita I. Zinchenko, D. Yu. Uryumtsev, Sergey Georgievich Krivoshchekov, Lyubomir I. Aftanas · 2019 · S S Korsakov Journal of Neurology and Psychiatry
  17. Severe Depressive Episode with Psychotic Symptoms and Type 2 Diabetes: A 2010–2017 Longitudinal Study
    Mariusz Jaworski, Mariusz Pańczyk, Andrzej M. Śliwczyński, Melania Brzozowska, Katarzyna Janaszek, Piotr Małkowski, Joanna Gotlib · 2019 · Medical Science Monitor
  18. Calidad de vida relacionada con la salud y Hemoglobina Glicosilada en pacientes con Diabetes Mellitus tipo 2
    Byron Eduardo Coello Viñán · 2020 · REVISTA EUGENIO ESPEJO
  19. Immunological substrates of depressive symptoms in patients with severe obesity: An exploratory study
    Victoria Stiglbauer, Stefanie Gamradt, Marie Scherzer, Jelena Brasanac, Christian Otte, Matthias Rose, Tobias Hofmann, Kim Hinkelmann, Stefan Michael Gold · 2021 · Cell Biochemistry and Function
  20. The Absence of Items Addressing Increased Appetite or Weight in Depressive-Symptom Questionnaires: Implications for Understanding the Link between Major Depressive Disorder, Antidepressants, and Obesity
    Andrés M. Treviño‐Alvarez, Marci E. Gluck, Susan L. McElroy, Alfredo B. Cuellar Barboza · 2024 · Brain Sciences
  21. The impact of a diabetes diagnosis on health and well‐being: Findings from the English Longitudinal Study of Ageing
    Camilla Böhme Kristensen, Joseph Chilcot, Sarah E. Jackson, Andrew Steptoe, Ruth A. Hackett · 2023 · Journal of Diabetes
  22. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
    Miguel Ángel Salinero-Fort, Jose M Mostaza-Prieto, Carlos Lahoz, Juan Cárdenas‐Valladolid, Víctor Iriarte-Campo, Eva Estirado, Francisca García-Iglesias, Teresa González-Alegre, Belén Fernández-Puntero, V Cornejo-del Río et al. · 2024 · BMJ Open
  23. Risk of new onset major depressive disorder among patients with varicose veins: A multi-institution database study
    Chun‐Yu Cheng · 2022 · Journal of Psychosomatic Research
  24. Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression
    Michael Tocco, John W. Newcomer, Yongcai Mao, Andrei Pikalov · 2023 · CNS Spectrums
  25. Incidence and Factors Associated with Hyperglycemia in Patients with First Hospitalization for Major Depression Disorder: A Large Cross-Sectional Sample
    Shuangyu Qi, Xu Yang, Kuan Zeng, Yi Li, Jun Ma · 2023 · Neuropsychiatric Disease and Treatment
  26. Development and Validation of a Community–Based Prediction Model for Depression in Elderly Patients with Diabetes: A Cross–Sectional Study
    Shanshan Li, Le Zhang, Boyi Yang, Yixiang Huang, Yuqi Guan, Nanbo Huang, Yingnan Wu, Wenshuo Wang, Qing Wang, Haochen Cai et al. · 2024 · Diabetes Metabolic Syndrome and Obesity
  27. Diabetes and depression were not associated in Venezuelan adults: The EVESCAM study, a national cross-sectional sample
    Juan Pablo Gonzalez-Rivas, William H. Polonsky, María M. Infante-García, Maritza Durán, Eunice Ugel, María Inés Marulanda, Jeffrey Ian Mechanick, Ramfis E Nieto-Martínez · 2019 · Primary care diabetes
  28. Effect of sertraline in patients with newly diagnosed depression and type 2 diabetes mellitus or hypertension: An observational study from south India
    C. Padmapriya, S. Pushkarapriya, N. Shanmugapriya, K.P. Sushmitha, S. Karthik, Muhasaparur Ganesan Rajanandh · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  29. Longitudinal associations of depression and diabetes with Alzheimer’s disease and related dementias risk among American Indian and Alaska Native peoples
    R. Turner Goins, Yuxi Vania Shi, María M. Corrada, Spero M. Manson, Joan O’Connell, Luohua Jiang · 2025 · The Journals of Gerontology Series A
  30. Prevalence of Metabolic Syndrome and Its Components in Patients With Major Depressive Disorder
    Asfand Yar Wali Faizan, Sheherzad Faizan, Sikandar Ilyas, Hammad Mudassar, HASSAN KHALID, Sidra Naseer, Iqra Naeem, Muhammad Zaryab Haider, Muhammad Irfan Jamil, Adeel Ahmed · 2025 · Cureus
  31. Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia: a comprehensive cross-sectional study
    Siyang Zheng, Zhi-Yang Wang, Limin Yang, Xiang-Yang Zhang · 2023 · BMC Psychiatry
  32. The role of immuno-metabolic depression features in the effects of light therapy in patients with depression and type 2 diabetes mellitus: A randomized controlled trial
    Sarah R. Vreijling, Layla Neuhaus, Annelies Brouwer, Brenda W.J.H. Penninx, Aartjan T.F. Beekman, Femke Lamers, Rick Jansen, Marijke A. Bremmer · 2024 · Journal of Psychosomatic Research
  33. Depression and sedentary behaviour in women with multiple sclerosis
    Eduarda F. A. Machado, Felipe von Glehn, Jeffer Eidi Sasaki, Carlos Bernardo Tauil, Ana Cristina de David · 2024 · Multiple Sclerosis and Related Disorders
  34. Antidepressants and Risk of Mortality in People with Depressive Disorder and Co-Occurring Type 2 Diabetes Mellitus: A 20-Year Population-Based Cohort Study
    Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, William Chi Wai Wong, Wing Chung Chang · 2026 · Psychotherapy and Psychosomatics
  35. Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review of 254,154,533 records
    Michele Fornaro, Chiara Di Lorenzo, Luca Steardo, Nicola Veronese, Brendon Stubbs, Davy Vancampfort, Dan J. Siskind, Marco Solmi · 2026 · European Neuropsychopharmacology
  36. The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol
    Nanna Lindekilde, Stine H. Scheuer, Femke Rutters, Jan Erik Henriksen, Katrine Hass Rubin, Mathias Lasgaard, Gregers S. Andersen, Frans Pouwer · 2020 · Systematic Reviews
  37. The Effects of Stress on Glycemic Control Brought on by Changes in Social Conditions Due to COVID-19
    Mio Masuda, Osamu Tomonaga · 2021 · Internal Medicine
  38. Factors Associated with Anxiety During COVID-19 Pandemic and Its Association with Hypertension in Saudi Arabia
    Badria Said, Maryam Othman Gharawi, Fatimah H. Dallak, Afnan Q. Maashi, Eman Hurissi, Sarah O Gharawi, Melia M Tarshi, Alanoud Ibrahim Hayyan, Suzan A Faqihi, Hafiz I. Al-Musawa et al. · 2023 · Patient Preference and Adherence
  39. A Randomized Controlled Trial Comparing the Effects of Vilazodone, Escitalopram, and Vortioxetine Monotherapy on the Metabolic Parameters in Patients With Major Depressive Disorder
    N Simple Santi, Sashi Bhusan Biswal, Birendra Narayan Naik, Jyoti Prakash Sahoo, Bhabagrahi Rath · 2024 · Cureus
  40. Mental Disorders, Antidepressants, and Type 2 Diabetes
    Rodrigo Barbachan Mansur, Roger S. McIntyre, Elisa Macedo Brietzke · 2018 · Archives of Pediatrics and Adolescent Medicine
  41. Assessment of Health-Related Quality of Life Among Patients Management Program of Chronic Diseases Type 2 Diabetes Mellitus
    Fajriansyah1,2, Iskandarsyah A3, IM Puspitasari1,4, Keri Lestari1,4 · 2020 · Indian Journal of Forensic Medicine & Toxicology
  42. Comorbidity Between Mood Disorders and Chronic Somatic Diseases, With a Focus on Cardiometabolic Disease, and Its Mechanistic Crosstalk
    Hongzhen Du, Gangqiang Du, Qian Zhang, Yixuan Zhao, Jilin Fan, Yufeng Zhou, Zihao Sun, Chen Li, Wei Li · 2026 · Depression and Anxiety
  43. Features of diabetes distress in patients with diabetes and their family caregivers
    Rui Hashimoto, Hironori Shimada · 2017 · Stress Science Research
  44. Brain stimulation for treatment-resistant depression
    Aluisio Rodrigues, Lisiane Martins, Nivaldo Ribeiro Villela, Laís Boralli Razza, André R. Brunoni · 2023 · Progress in brain research
  45. Exploring the Role of Physical Exercise to Improve Cardiorespiratory Fitness and Muscular Strength Among Individuals With Severe Mental Disorder
    Álvaro López-Moral, Diego Munguía‐Izquierdo, Javier Bueno‐Antequera · 2023 · Advances in psychology, mental health, and behavioral studies (APMHBS) book series
  46. Prevalence and Major Risk Factors of Type 2 Diabetes Mellitus Among Adult Psychiatric Patients in Taif Mental Hospital in Saudi Arabia
    Yasir Awadh Altuwairqi · 2024 · SAS Journal of Medicine
  47. Depression and Cardiovascular Risk: Epidemiology, Mechanisms, and Implications
    Jessica K. Hatch, Benjamin I. Goldstein · 2019 · Elsevier eBooks
  48. Diabetes mellitus in patients using psychotropic medications: How does it work?*
    Marcin Kosmalski, Monika Różycka-Kosmalska, Joanna Sikora, Tadeusz Pietras · 2021 · Postępy Higieny i Medycyny Doświadczalnej
  49. Mental disorders and physical activity: Epidemiological analyses using Australian datasets
    Shuichi Suetani · 2019 · The University of Queensland
  50. Major depressive disorder but not bipolar disorder and schizophrenia is a causal factor for type 2 diabetes as determined by Mendelian randomization
    Heejin Jin, Jeewon Lee, Sohee Oh, Sanghun Lee, Sungho Won · 2020 · medRxiv
  51. Physical Activity in Clinical Psychiatry: Increasing exercise in major depressive disorder and prevalence of sedentary behavior in severe mental illness
    Frank R Kruisdijk · 2020 · Pure Amsterdam UMC
  52. Sporttherapie bei Depression
    Marco Herbsleb · 2021 · Der Schmerzpatient
  53. Depression, metabolisches Syndrom und kardiovaskuläre Erkrankungen
    Michael Deuschle, Kai G. Kahl, Ulrich Schweiger · 2019 · Elsevier eBooks
  54. Diabetes mellitus
    Hans‐Peter Kapfhammer · 2022 · Springer eBooks
  55. Mendelian randomization shows depression increase the risk of type 2 diabetes
    Sungho Won, Heejin Jin, Jeewon Lee, Sanghun Lee, Sohee Oh · 2023 · Research Square
  56. IDF2022-1030 Association between Diabetic Neuropathy, Anxiety, Depression and Demographics in an Africa Setting
    Vincent A. Adzika, A. Perdro · 2023 · Diabetes Research and Clinical Practice
  57. Methylglyoxal is the main culprit to impairing neuronal function: mediated through tryptophan depletion
    Md. Samsuzzaman, Jae Hyuk Lee, Seong‐Min Hong, Hyun Jun Park, Keun‐A Chang, Hyun-Bum Kim, Myoung Gyu Park, Hyeyoon Eo, Myung Sook Oh, Sun Yeou Kim · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Diabetes, saúde mental e qualidade de vida relacionada à saúde em estudo de base populacional
    Cecilia Correa Avila · 2020
  59. Validation of Diabetes Prediction Scores: Does adding a high risk for depression increase the area under the curve?
    Miguel Ángel Salinero-Fort, José María Mostaza, Carlos Lahoz, Juan Cárdenas‐Valladolid, Víctor Iriarte-Campo, E. Estirado-de Cabo, Francisca García-Iglesias, Teresa González-Alegre, Belén Fernández-Puntero, V Cornejo-del Río et al. · 2023 · medRxiv
  60. Changes in Exercise Performance in Patients During a 6-Week Inpatient Psychiatric Rehabilitation Program and Associated Effects on Depressive Symptoms
    Philipp Birnbaumer, Claudia Traunmüller, Christian Natmessnig, Birgit Senft, Caroline Jaritz, Sigurd Hochfellner, Andreas Richard Schwerdtfeger, Peter Hofmann · 2024 · Journal of Functional Morphology and Kinesiology
  61. The Problem of Assessing the Extent of Somatic Comorbidity in Patients with Major Depressive Disorder and Bipolar Disorder: Metabolic Syndrome, Cardiovascular Diseases, and Type II Diabetes Mellitus
    V. E. Makeenko, Diana S. Shumskaia, Alexander O. Kibitov · 2024 · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
  62. Grundlagen der Diagnostik und Therapie
    2024 · Elsevier eBooks
  63. Prevalence and Risk Factors of Comorbid Type 2 Diabetes Mellitus in Adults With Severe Mental Disorders: A Retrospective Study
    Jiao Hu, Xida Wang, X Huang, Zhuozhuo Cheng, Huiling Ye, Haofeng Xu, Youping Wang · 2025 · ALPHA PSYCHIATRY
  64. Additional file 2 of The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol
    Lindekilde, N., Scheuer, S., Femke Rutters, Henriksen, J. E., Rubin, K. H., Lasgaard, M., Andersen, G. S., Pouwer, F. · 2020 · Figshare
  65. Additional file 1 of The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol
    Lindekilde, N., Scheuer, S., Femke Rutters, Henriksen, J. E., Rubin, K. H., Lasgaard, M., Andersen, G. S., Pouwer, F. · 2020 · Figshare
  66. Risk of mortality and complications in people with depressive disorder and co-occurring diabetes mellitus: a systematic review and meta-analysis
    M.T.H. Ho, J.K.N. Chan, W.C.Y. Chiu, L.L.W. Tsang, H.K.Y. Lo, S.Y.L. Wong, K.S.W. Chan, M.M.C. Wong, H.H. Wong, W.C. Lam et al. · 2026 · Neuroscience Applied
  67. Antidepressants and type 2 diabetes : a pharmacoepidemiological approach
    Thi Bich Ngoc Nguyen · 2019
  68. Résistance à l’Insuline du Système Sérotoninergique : Implication dans les Troubles de l’Humeur Comorbides au Diabete De Type 2
    Hugo Martin · 2021 · theses.fr (ABES)
  69. Mental health burden associated with specific ocular conditions among Medicare Advantage beneficiaries with type 2 diabetes: examining the impact of glaucoma, cataracts, retinopathy, and dry eye on unhealthy mental health days
    Michael D. Twa, Tonghui Xu, Patrick Dang, Lucy Kehinde-Darnell, Jessica M. Dobbins, Winston R. Liaw, Omolola E. Adepoju · 2026 · Frontiers in Public Health
  70. Psychopathological aspects of the diabetic patient from the perspective of mental health
    Camelia-Lucia Bakri · 2021 · Medic ro
  71. Is abnormal brain insulin action implicated in the biology of depression? A pilot neuroimaging study in adolescents
    Kateryna Maksyutynska, Nicolette Stogios, Vittal Korann, Laurie Hamel, Daphne J. Korczak, Benjamin I. Goldstein, Gary J. Remington, Marcos Sanches, Margaret Hahn, Ariel Graff‐Guerrero et al. · 2026 · Neuropsychopharmacology